Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions.

Ozsu S, Oztuna F, Mentese A, Abul Y, Ozlu T.

Clin Respir J. 2016 Jan;10(1):61-6. doi: 10.1111/crj.12186. Epub 2014 Aug 4.

PMID:
25043397
2.

Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.

Lee SH, Lee EJ, Min KH, Hur GY, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Lee SY.

Clin Biochem. 2013 Oct;46(15):1484-8. doi: 10.1016/j.clinbiochem.2013.03.018. Epub 2013 Apr 6.

PMID:
23570862
3.

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.

Wang M, Zhang Z, Wang X.

Clinics (Sao Paulo). 2014;69(12):799-803. doi: 10.6061/clinics/2014(12)02.

4.

Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.

Gaspar MJ, De Miguel J, García Díaz JD, Díez M.

Anticancer Res. 2008 Sep-Oct;28(5B):2947-52.

5.

Pleural fluid cell-free DNA in parapneumonic pleural effusion.

Santotoribio JD, Cabrera-Alarcón JL, Batalha-Caetano P, Macher HC, Guerrero JM.

Clin Biochem. 2015 Oct;48(15):1003-5. doi: 10.1016/j.clinbiochem.2015.07.096. Epub 2015 Jul 31.

PMID:
26234638
6.

Determination of tissue polypeptide-specific antigen in pleural fluid and serum from patients with pleural effusion.

Villena V, Echave-Sustaeta J, Lopez-Encuentra A, Martin-Escribano P, Estenoz-Alfaro J, Ortuño-de-Solo B.

Int J Biol Markers. 1995 Jul-Sep;10(3):161-5.

PMID:
8551059
7.

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman GE, Thornquist MD, Liu G, de Perrot M, Tsao MS, Goparaju C.

N Engl J Med. 2012 Oct 11;367(15):1417-27. doi: 10.1056/NEJMoa1115050. Erratum in: N Engl J Med. 2012 Nov;367(18):1768.

8.

Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.

Riantawan P, Sangsayan P, Bangpattanasiri K, Rojanaraweewong P.

Respiration. 2000;67(1):24-9.

PMID:
10705258
9.

Osteopontin is upregulated in malignant and inflammatory pleural effusions.

Moschos C, Porfiridis I, Psallidas I, Kollintza A, Stathopoulos GT, Papiris SA, Roussos C, Kalomenidis I.

Respirology. 2009 Jul;14(5):716-22. doi: 10.1111/j.1440-1843.2009.01536.x. Epub 2009 May 19.

PMID:
19476604
10.

Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions.

Lin MC, Chen YC, Wu JT, Ko YC, Wang CC.

Chest. 2009 Jul;136(1):205-211. doi: 10.1378/chest.08-1134. Epub 2009 Mar 2.

PMID:
19255287
11.

Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.

Bishara J, Goldberg E, Ashkenazi S, Yuhas Y, Samra Z, Saute M, Shaked H.

Ann Thorac Surg. 2009 Jan;87(1):251-4. doi: 10.1016/j.athoracsur.2008.09.047.

PMID:
19101307
12.

Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.

Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J.

Cancer. 1996 Aug 15;78(4):736-40.

13.

High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.

Kolditz M, Halank M, Schiemanck CS, Schmeisser A, Höffken G.

Eur Respir J. 2006 Jul;28(1):144-50. Epub 2006 Feb 15.

14.

Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.

Ozsu S, Abul Y, Mentese A, Bektas H, Uzun A, Ozlu T, Porcel JM.

Respirology. 2013 May;18(4):657-62. doi: 10.1111/resp.12038.

PMID:
23286371
15.

Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.

Liao ND, Chiang TA, Lee WY.

Cancer Cytopathol. 2013 Dec;121(12):695-702. doi: 10.1002/cncy.21324. Epub 2013 Jul 16.

16.

Soluble receptor-binding cancer antigen expressed on SiSo cells in pleural fluid: a potential diagnostic marker for malignant pleural effusion.

Aoe K, Hiraki A, Maeda T, Murakami T, Yamazaki K, Sugi K, Takeyama H.

Chest. 2004 Oct;126(4):1195-7.

PMID:
15486382
17.

The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.

Fiorelli A, Morgillo F, Fasano M, Vicidomini G, Di Crescenzo VG, Di Domenico M, Accardo M, Santini M.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):263-9. doi: 10.1093/icvts/ivs466. Epub 2012 Nov 28.

18.

Diagnostic value of ferritin, haptoglobin, alpha 1-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation.

Alexandrakis M, Coulocheri S, Kyriakou D, Bouros D, Xirouhaki N, Siafakas N, Castanas E, Eliopoulos GD.

Respir Med. 1997 Oct;91(9):517-23.

19.

Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.

Yang WB, Liang QL, Ye ZJ, Niu CM, Ma WL, Xiong XZ, Du RH, Zhou Q, Zhang JC, Shi HZ.

PLoS One. 2012;7(7):e40450. doi: 10.1371/journal.pone.0040450. Epub 2012 Jul 9.

20.

Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.

Chang SC, Hsu YT, Chen YC, Lin CY.

Arch Intern Med. 1994 May 23;154(10):1097-101.

PMID:
8185423

Supplemental Content

Support Center